Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Cocrystal Pharma Inc (COCP) just unveiled an announcement.
Cocrystal Pharma, Inc. has released an update on the progress of its promising compound, CDI-42344, which is currently in clinical development as a treatment and preventive measure for influenza A. The announcement has triggered interest among investors, as it marks a significant step in the company’s efforts to combat this common and challenging illness.
Find detailed analytics on COCP stock on TipRanks’ Stock Analysis page.
